Mathieu, Véronique <br/><br/>
Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.  [electronic resource] 

 -  The Journal of investigative dermatology  Oct 2007 
 - 2399-410 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/sj.jid.5700869  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Apoptosis--drug effects<br/>Cathepsin B--metabolism<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Dacarbazine--analogs & derivatives<br/>Disease Models, Animal<br/>Female<br/>Galectin 1--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HSP72 Heat-Shock Proteins--physiology<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Knockout<br/>RNA, Small Interfering--pharmacology<br/>Skin Neoplasms--drug therapy<br/>Temozolomide<br/>Xenograft Model Antitumor Assays